Clinical Trials

This clinical trial is for patients with congenital hyperinsulinism (HI) who are experiencing low blood sugar on their current treatment.

In the Chan lab, we are motivated by our belief that no child should die from a preventable cause. To advance our shared goal, our work is rooted in rigorous science while cultivating a culture of intellectual curiosity, collaboration, and innovation.

The CHOP Kidney Stone Frontier Program integrates multidisciplinary clinical expertise in urology and nephrology with advanced multi-omics research to develop new diagnostic tests that will transform the management of children and adolescents with kidney stone disease.

The purpose of this study is to find out if the study drug, Obinutuzumab, is effective in achieving a complete renal response for adolescents with active class III or IV lupus nephritis.

Research Family Partners assists study teams with community engagement and incorporating the patient and family voice in research.